ntla-2001
intellia therapeutics
['ntla-2001', 'dose,trial', 'crispr']
read through the #aha2022 abstracts and searched for this crispr hurdles its first phase i trial "...circulating serum ttr proteins were rapidly and profoundly reduced by at least 90% in all patients 28 days after administration of a single intravenous dose of ntla-2001." 
UP Med 2022 ????|| Molecular Biology major
Interested in #Radiology #InterventionalRadiology #DataScience #Statistics
Passionate about #Medicine #MedEd #FOAMed